Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Change in Cash: 2019-2024

Historic Change in Cash for Relay Therapeutics (RLAY) over the last 6 years, with Dec 2024 value amounting to -$20.0 million.

  • Relay Therapeutics' Change in Cash fell 226.82% to -$22.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$60.7 million, marking a year-over-year decrease of 13853.74%. This contributed to the annual value of -$20.0 million for FY2024, which is 152.71% down from last year.
  • Relay Therapeutics' Change in Cash amounted to -$20.0 million in FY2024, which was down 152.71% from -$7.9 million recorded in FY2023.
  • In the past 5 years, Relay Therapeutics' Change in Cash registered a high of $405.7 million during FY2020, and its lowest value of -$165.8 million during FY2021.
  • Moreover, its 3-year median value for Change in Cash was -$20.0 million (2024), whereas its average is -$52.1 million.
  • In the last 5 years, Relay Therapeutics' Change in Cash soared by 206.89% in 2020 and then tumbled by 152.71% in 2024.
  • Yearly analysis of 5 years shows Relay Therapeutics' Change in Cash stood at $405.7 million in 2020, then plummeted by 140.88% to -$165.8 million in 2021, then increased by 22.62% to -$128.3 million in 2022, then soared by 93.82% to -$7.9 million in 2023, then slumped by 152.71% to -$20.0 million in 2024.